Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 8986 AL 9000

Inspiratory muscle training for people with Parkinson's disease: a protocol for a mixed methods randomised controlled trial

Fernandes Barreto de Mendonca J, Preston E, Flynn A, Bissett B.

BMJ Open Respir Res. 2025 Jun 22;12(1):e003120. doi: 10.1136/bmjresp-2024-003120.

Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population

Yadav R, Dey S, Kumar R, Mohanan AP, Vasudevan GT, Harish M, Kamble N, Holla VV, Mahale RR, Mailankody P, Debnath M, Saini J, Kumar K, Mahadevan A, Subramanian S, Alladi P, Datta I, Sreekumarannair BV, Thomas P, Mehta A, Stezin A, Ingalhalikar M, Ramdas S, Bathula DR, Pal PK.

PLoS One. 2025 Jun 26;20(6):e0325624. doi: 10.1371/journal.pone.0325624. eCollection 2025.

GAN-based Denoising for Scan Time Reduction and Motion Correction of 18 F FP-CIT PET/CT: A Multicenter External Validation Study

Han H, Choo K, Jeon TJ, Lee S, Seo S, Kim D, Kim SJ, Lee SH, Yun M.

Clin Nucl Med. 2025 Oct 1;50(10):e580-e588. doi: 10.1097/RLU.0000000000006040. Epub 2025 Jul 1.

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Wong KM, Maroofian R, Meier K, Diegmann S, Tkemaladze T, Alvi JR, Tasharrofi B, Efthymiou S, Munchau A, Korenke GC, Almontashiri N, Eyaid W, Kashgari A, Alotaibi M, Gärtner J, Huppke B, Asadollahi M, Chikvinidze G, Keramatipour M, Sultan T, Thiele H, Nürnberg P, Gräler MH, Houlden H, Huppke P.

Mov Disord. 2025 Sep;40(9):1836-1850. doi: 10.1002/mds.30258. Epub 2025 Jul 1.

Comparison of Two MPTP Doses on Mouse Behaviors and Pathologies

Qi Y, Zhang Z, Xue J, Yao S, Lu X, Tang X.

FASEB J. 2025 Jul 15;39(13):e70822. doi: 10.1096/fj.202500467RR.

Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability

Mouradian MM, Stoessl AJ, Lang AE.

Mov Disord. 2025 Sep;40(9):1778-1790. doi: 10.1002/mds.30259. Epub 2025 Jul 10.

Characteristics and Validity of Commercially Available Technologies Analyzing Voice Features to Assess Parkinson's Disease

Dean JM, Iankova V, Roberts A, Schneider SA.

Mov Disord Clin Pract. 2026 Jan;13(1):60-70. doi: 10.1002/mdc3.70214. Epub 2025 Jul 11.

Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder

Yska HAF, Golse M, Beerepoot S, Hayer S, Bergner C, de Paiva ARB, Marelli C, Palacios NJ, Osorio YL, Huiban C, Franke G, Wortmann F, Holtick U, Ayrignac X, van der Knaap MS, Schöls L, Perlbarg V, Galanaud D, de Witte MA, Wolf NI, Nguyen S, Mochel F; and the International CSF1R‐RD Working Group.

Mov Disord. 2025 Sep;40(9):1826-1835. doi: 10.1002/mds.30282. Epub 2025 Jul 11.

Deciphering the Janus-Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis

Dai Y, Bi M, Jiao Q, Du X, Chen X, Yan C, Jiang H.

Mov Disord. 2025 Nov;40(11):2299-2313. doi: 10.1002/mds.30294. Epub 2025 Jul 14.

Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease: A Randomized Noninferiority Trial

Vaughan CP, Morley JF, Lehosit J, McGwin G, Muirhead L, Khakharia A, Johnson TM 2nd, Evatt ML, Sergent T, Burgio KL, Markland AD.

JAMA Neurol. 2025 Sep 1;82(9):925-931. doi: 10.1001/jamaneurol.2025.1904.

Fasting and postprandial Ghrelin levels in Parkinson's disease: a systematic review and meta-analysis

Gouveia HJCB, Dos Santos-Júnior OH, Frasnelli J.

NPJ Parkinsons Dis. 2025 Jul 14;11(1):212. doi: 10.1038/s41531-025-01066-0.

A personalised, gait training telerehabilitation programme for people with Parkinson's Disease: A long-term pilot study

Lopane G, D'Ascanio I, Corzani M, Petrone V, Calandra-Buonaura G, La Porta F, Cortelli P, Gazit E, Brozgol M, Thumm Cornejo P, Giladi N, Ferrari A, Tacconi C, Chiari L, Palmerini L, Hausdorff JM.

Clin Rehabil. 2025 Aug;39(8):1034-1047. doi: 10.1177/02692155251355880. Epub 2025 Jul 14.

Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

Colucci F, Gozzi A, Antenucci P, Casetta I, Maistrello L, Antonioni A, Raho EM, Tecilla G, Capone JG, Sensi M.

Mov Disord Clin Pract. 2025 Nov;12(11):2034-2042. doi: 10.1002/mdc3.70231. Epub 2025 Jul 15.

Towards Adaptive Deep Brain Stimulation for Non-Motor Symptoms in Parkinson's Disease?

Swinnen BEKS, Hoy CW, Little SJ.

Mov Disord. 2025 Sep;40(9):1759-1777. doi: 10.1002/mds.30212. Epub 2025 Jul 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias